CDx development process

Comprehensive solution, deliberate approach


Our thorough, end-to-end process – combined with our disciplined approach to development and integrated technology capabilities – enables pharmaceutical partners to advance and accelerate clinical and research programs aimed at personalizing care for cancer patients. From early biomarker hypothesis testing to global acceleration, we can partner with you at any stage of your drug development journey to help maximize your program’s probability of success.

CDx Development Process


Biomarker research tools and support

pre-clinical phase
Early stage

From reagent development to prototype assay validation

Early Stage Phase
Late stage


Registrational trial support and submission

Late Stage Phase


Market preparation, sales readiness and commercial acceleration

Launch Phase

We position you for success


From early or late stage development through global commercialization, we employ our world-class capabilities and deep expertise to build a solid framework for your diagnostic strategy and help bridge the gap to patient access at every step along the way.